ABSTRACT
Muchos estudios han descrito la mayor susceptibilidad pediátrica a la aparición de errores; los niños son especialmente vulnerables, por lo que corresponde extremar la vigilancia para conseguir los mejores resultados terapéuticos al menor riesgo. Muchos son los trabajos relativos a la prescripción de fármacos en pediatría en condiciones distintas a las autorizadas. Los estudios señalan que aproximadamente el 50% de los fármacos empleados en niños se utilizan en condiciones diferentes a las autorizadas (off label o unlicensed), y que en aproximadamente un 70% de los pacientes pediátricos al menos se prescribe un fármaco bajo esas condiciones.
Many studies have reported increased pediatric susceptibility to the development of errors; children are more vulnerable, so it is very important to guarantee the best therapeutic results at the lowest risk. There are many studies related to prescription of drugs in pediatrics under conditions other than those authorized. Studies show that approximately 50% of the drugs used in children are off label or unlicensed, and in about 70% of pediatric patients at least one drug is prescribed under those conditions.
Subject(s)
Child , Humans , Drug Utilization/standards , Medication Errors/prevention & control , Patient SafetyABSTRACT
Many studies have reported increased pediatric susceptibility to the development of errors; children are more vulnerable, so it is very important to guarantee the best therapeutic results at the lowest risk. There are many studies related to prescription of drugs in pediatrics under conditions other than those authorized. Studies show that approximately 50% of the drugs used in children are off label or unlicensed, and in about 70% of pediatric patients at least one drug is prescribed under those conditions.